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It has been shown that self-reactive T cells can be detected in the periphery. In this issue of Immunity, Yu et al.
(2015) show that clonal deletion prunes the T cell repertoire but does not eliminate self-reactive T cell clones.T cells play a pivotal role in protecting the
host from infections by effectively re-
cognizing microbial pathogens, and this
cognate recognition is primarily mediated
by specific ab heterodimer T cell recep-
tors (TCR). However, to recognize the
vast number of potential pathogens, na-
ture adopted a simple yet elegant solution
by recombining variable, diversity, and
junctional DNA with constant chains of
the TCR to generate a high diversity of
TCR that are capable of recognizing
foreign epitopes. Due to the rearrange-
ments of numerous gene segments
(e.g., >20 Vb and >70 Va), a high combi-
natorial diversity of a TCR repertoire can
be achieved (Davis and Bjorkman, 1988).
The price to pay is the possibility of self-
reactive T cells with subsequent autoim-
mune disease. Indeed, we observed hu-
man T cells highly reactive to self-myelin
proteins over 25 years ago in both healthy
subjects and patients with autoimmune
disease (Ota et al., 1990). How nature bal-
ances the need for almost an infinite
capability of recognizing microbial anti-
gens without ‘‘infinite’’ autoimmune dis-
ease has been a critical question in the
field of immunology, with mouse models
emphasizing the central role for thymic
selection. Here, Yu et al. (2015) beautifully
demonstrate that although thymic clonal
deletion prunes the T cell repertoire, this
mechanism does not eliminate self-spe-
cific T cells and suggest that to do so
would create holes in the repertoire that
pathogens could readily exploit.
Investigation of central tolerance goes
back to 1959 when Burnet postulated
that T cells express one TCR with a given
specificity and autoreactive T cells are
clonally deleted from the T cell popula-
tion during thymic development (Burnet,
1959). During the decades since then,
this concept was reinforced by studies
using TCR transgenic mice strains in
which T cells expressing a TCR specific788 Immunity 42, May 19, 2015 ª2015 Elsevifor a superantigen, experimentally over-
expressed in the thymus, are efficiently
deleted from the repertoire (reviewed in
[Hogquist et al., 2005]). However, although
clonal deletion is thought to eliminatemost
self-reactive T cells, a certain amount of
self-reactive T cells is common in the pe-
riphery (Ota et al., 1990). The presence of
self-reactive T cells in the periphery argues
for the possibility to escape clonal deletion
and also for the presence of peripheral
mechanisms preventing these cells from
facilitating immune responses.
Estimates of the naive human T cell
repertoire reveal a mathematical gap be-
tween TCR diversity with different antigen
specificities and possible peptide se-
quences presented by MHC molecules.
Although TCRs are highly specific for their
cognate antigen, this discrepancy argues
for a certain degree of degeneracy with a
single TCR potentially recognizing over a
million different peptides in the context of
MHC class I (Wooldridge et al., 2012). To
clarify the extent of TCR cross-reactivity,
Birnbaum et al. recently developed a sys-
tem to identify potential MHC-presented
peptide ligands by combining peptide-
MHC libraries with deep sequencing. Hun-
dreds of peptides were identified that
could bind to one of the tested TCRs and
possessed conserved recognition motifs
in the TCR binding residues bearing close
similarity to the TCRs known antigen (Birn-
baum et al., 2014). Thus, shaping the TCR
repertoire is further complicated by the
tremendous degree of TCR degeneracy in
recognizing peptide in the context ofMHC.
In a prior study from the Davis labora-
tory, Su et al. observed that the frequency
of virus-specific human memory CD4
T cells in the periphery is the same be-
tween seropositive and seronegative hu-
man donors (Su et al., 2013). They further
determined that the memory-like pheno-
type in seronegative donors was acquired
by low-affinity TCR engagement with un-er Inc.related microbe-derived peptides. In the
current study, Yu et al. investigated the
fate of self-specific CD8 ab T cells. For
the initial experiment, the authors isolated
T cells from healthy donors that tested
seronegative for CMV, HIV, and hepatitis
C virus, and were unlikely to be infected
with the H5N1 virus, and then determined
the respective antigen-specific CD8 T cell
frequency utilizing specific peptide HLA-
A*0201 tetramers to enrich for naive anti-
gen-specific CD8 T cells. Additionally,
HLA-A*0201 tetramer enrichment was
used to determine the frequency of CD8
T cells specific for endogenous peptides,
fructosebisphosphate aldolase, andkera-
tin, as well as the autoimmune disease-
associated epitopes of preproinsulin and
glutamic acid decarboxylase 65. A similar
frequency of CD8 T cells recognizing
endogenous and foreign peptides was
found in the blood of healthy volunteers.
The investigators then examined the
efficiency of clonal deletion by comparing
the frequency of SMCY-specific CD8
T cells, a Y chromosomeencoded antigen,
in male and female healthy volunteers.
Interestingly, only a reduction to 1/3 in
male donors was observed, indicating
that clonal deletion is not particularly effi-
cient. Using the mouse H-Y system in
combination with the same tetramer en-
richment method, again only a slight non-
significant reduction of SMCY3-specific
CD8 T cells in male mice was observed,
further emphasizing the lack of efficiency
for thymic deletion.
Given that self-reactive CD8 T cells can
bypass clonal deletion, other mechanisms
to prevent autoimmune responses must
be operative. Yu et al. first investigated
the avidity of human SMCY-specific CD8
T cells by generating SMCY-specific CD8
T cell clones frommale and female donors.
T cell clones derived from male and fe-
males showed an equal repertoire of Vb
usage excluding the idea that peripheral
Figure 1. Clonal Deletion Prunes the T Cell Repertoire without Eliminating Self-Reactive
T Cells
Self-reactive CD8 T cells can escape clonal deletion. Upon activation in the periphery, however, self-reac-
tive T cells show a lower activation profile and a differential gene-expression pattern compared to foreign-
reactive CD8 T cells.
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Previewsexpansion of single T cell clones accounts
for the enhanced frequency. In functional
assays, both male and female-derived
T cell clones showed a similar sensitivity
to SMCY and both killed target cells
with the same efficiency. The authors
concluded that other tolerance mecha-
nisms than difference in TCR sensitivity
must play a role in controlling self-reactive
T cells in the periphery and analyzed
single-cell gene expression in male
and female SMCY-specific T cells. They
observed distinct patterns of gene expres-
sion betweenmale and female CD8 T cells
and identifiedagroupof four genes—Egr2,
Il2ra, Il21r, and Bcl-xl—that are robustly
expressed together in female, but not
male-derived, T cells. To confirm the latter
observation, the authorsmeasured IL-2Ra
and IL-21R surface expression in stimu-
lated self-specific and foreign-specific
CD8 T cells. While frequencies of foreign
antigen-specific CD8 T cells increased in
numbers as did surface expression of IL-
2Ra and IL-21R, self-specific CD8 T cell
numbers did not, arguing for a difference
in activation and phenotype contributing
to a mechanism of tolerance (Figure 1).
Finally, Yu et al. utilized tetramers to
assess the frequency of different peptidevariants of the HCV protein NS3 epitope
KLVALGNIAV that is presented in the
context of HLA-A*0201. They investigated
T cell epitope coverage by generating
epitopes with exchanging all possible
amino-acid variants at position five. Inter-
estingly, all possible variants were detect-
able, although with a higher frequency for
epitopes with the general capability of
forming a higher variety of protein-protein
interactions. CD8 T cell clones specific for
different epitopes showed a similar sensi-
tivity for the cognate variant peptide and
were able to kill target cells to a similar
extent.
This study provides deep mechanistic
insights into the long-standing observa-
tion that only highly self-reactive T cell
clones are clonally deleted, whereas
weaker self-reactive clones are released
into the periphery, presumably to cover a
broad pattern of pathogen recognition
(Vidovic and Matzinger, 1988). Thus,
T cell recognition walks a tight-rope be-
tween the needs of the species to recog-
nize all possible microbial antigens while
not allowing for high-affinity autoreactive
T cells to occur. However, if high-affinity
autoreactive T cells are deleted, why are
autoimmune diseases so common? StudyImmunityof risk variants with genome-wide associ-
ation studies provide an unbiased view of
the biological pathways disrupted across
human autoimmune diseases. These in-
vestigations broadly indicate that genetic
variants lead to decrease activation
thresholds of multiple immune cell types,
including T cells (Farh et al., 2015). Thus,
while in healthy subjects clonal deletion
of high-affinity autoreactive CD4 cells is
sufficient for health, autoimmune disease
occurs when hundreds of genetic variants
and environmental factors induce lower
activation threshold in the lower-affinity
autoreactive T cells identified in this in-
vestigation. Thus the direct investigation
of human responses to microbial anti-
gens as opposed to the useful yet some-
times extreme phenotypes engendered
in animal models provides a different
perspective on the role of thymic selection
in shaping the immune repertoire. Finally,
understanding how genetic variation
associated with risk of autoimmunity influ-
ences clonal deletion that prunes the T cell
repertoire might provide new avenues for
therapeutic intervention prior to the onset
of human autoimmune diseases.
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